Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study

BACKGROUND: Despite high HIV co-infection prevalence in Ethiopian visceral leishmaniasis (VL) patients, the adequacy of antileishmanial drug exposure in this population and effect of HIV-VL co-morbidity on pharmacokinetics of antileishmanial and antiretroviral (ARV) drugs is still unknown. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kip, Anke E, Blesson, Séverine, Alves, Fabiana, Wasunna, Monique, Kimutai, Robert, Menza, Peninah, Mengesha, Bewketu, Beijnen, Jos H, Hailu, Asrat, Diro, Ermias, Dorlo, Thomas P C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050768/
https://www.ncbi.nlm.nih.gov/pubmed/33677546
http://dx.doi.org/10.1093/jac/dkab013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050768/
https://www.ncbi.nlm.nih.gov/pubmed/33677546
http://dx.doi.org/10.1093/jac/dkab013

Ejemplares similares